Primary Job Title Chairman Primary Organization 
Acusphere
Location Philadelphia, Pennsylvania, United States Regions Greater Philadelphia Area, Great Lakes, Northeastern US Gender Male
LinkedIn View on LinkedIn
Mr. Martyn Greenacre formerly served as a director of Cephalon, Inc. and as Chairman of BMP Sunstone Corporation, a pharmaceutical company based in China which had grown to over $100 million in revenue since he joined at the formation stage in 2004 and was then sold to Sanofi-Aventis in February 2011.
Mr. Greenacre also served as Chief
Executive Officer and director of Delsys Pharmaceutical Corporation, a formulation and drug delivery system company; as President and Chief Executive Officer and as a director of Zynaxis Inc., a biopharmaceutical company; and as Chairman Europe, SmithKline Beecham Pharmaceutical Company.
He joined SmithKline & French in 1973, where he held positions of increasing responsibility in its European organization. Mr. Greenacre serves as Chairman of Life Mist Technologies, Inc., a fire suppression equipment company, and as a director of Curis, Inc. and Neostem, Inc.
